Your browser doesn't support javascript.
Hospital readmissions of patients with COVID-19: causes, features, outcomes
Meditsinskiy Sovet ; 2022(23):335-342, 2022.
Article in Russian | Scopus | ID: covidwho-2226501
ABSTRACT
Introduction. On average, 10% of patients hospitalized due to new coronavirus infection (COVID-19) will be readmitted. To date, the reasons for readmission and the characteristics of these cases are not fully presented. The aim of the study was to analyze readmissions of COVID-19 patients to identify the causes of readmission, clinical features, examination data and treatment outcomes. Materials and methods. The study was performed retrospectively by using electronic records of the medical cases of the St. Petersburg City Hospital of St. George. Inclusion criteria 1) the presence of two or more hospitalizations during 2020–2021;2) COVID-19 confirmed by polymerase chain reaction within 14 days before or during the first hospitalization, or the detection of changes in the lungs with a high probability associated with COVID-19 during primary computed tomography. One hundred and two people met the specified criteria. Results. In 85% of cases, the cause of re-admission was symptoms of respiratory infection;in 13% – thrombotic events (pulmonary embolism, acute cerebrovascular accident, deep vein thrombosis of the lower extremities);12% – severe pain syndrome of various localizations;11%-infectious and inflammatory processes;9% – antibiotic-associated diarrhea;5% – atrial fibrillation and less often other pathologies. Patients with respiratory symptoms had a high degree of respiratory failure, an increase in the volume of affected lung tissue and an increase in the content of various markers of inflammation in the blood when compared with the data of the initial examination. Nine percent of patients died during hospitalization. Conclusions. The leading cause of repeated inpatient treatment of COVID-19 patients were symptoms of reactivation of the infection with a number of indicators of a greater severity of this "second wave” of the disease. Further studies are required to reduce the risk of repeated inpatient treatment. © 2022, Remedium Group Ltd. All rights reserved.
Keywords

Full text: Available Collection: Databases of international organizations Database: Scopus Language: Russian Journal: Meditsinskiy Sovet Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: Scopus Language: Russian Journal: Meditsinskiy Sovet Year: 2022 Document Type: Article